Effi cient One-Step Production of Microencapsulated Hepatocyte Spheroids with Enhanced Functions
Hon Fai Chan , Ying Zhang , and Kam W. Leong * sources in clinical applications. [ 2 ] Besides, given that many cell types are fragile and highly vulnerable to shear forces, the microcapsule/microgel layer can shield the enclosed cells from shear damage in bioreactor culture. [ 3 ] Finally, the encapsulation material itself or entrapped growth factors provide localized delivery of mechanical and biochemical cues to support or stimulate the functions or differentiation of the encapsulated cells. [4] [5] [6] The intrinsic characteristics associated with microcapsules/microgels such as short diffusion distance and high surface-to-volume ratio have spurred interests to use microencapsulated cells to treat various diseases. [ 2, 7 ] One notable example is the development of bioartifi cial liver. Most of the extracorporeal bioartifi cial liver systems currently examined in clinical trials involve a hollow fi ber design where individual hepatocytes are immuno-isolated via hydrogel entrapment or membrane compartmentalization. [ 8 ] While the membrane offers protection from immune attack and shear force, it also creates a diffusion barrier to mass exchange. [ 9 ] In addition, fl ow rates within the bioreactors are low (100-200 mL min −1 ) 
Introduction
The past decades have witnessed the exciting advances of cell microencapsulation technology in the medical fi eldbeginning with the use of alginate-polylysine capsules for islet transplantation. [ 1 ] The envelopment of tissues or cells in microcapsules and microgels with semi-permeable membrane can protect the enclosed cells from the host immune system upon transplantation, facilitating the use of xenogeneic cell www.small-journal.com compared with those of in vivo perfusion (≈1500 mL min −1 ) due to resistance within the fi bers. [ 10 ] Entrapment of hepatocytes into microgels has been shown to preserve hepatocyte functions when they were cultured in bioreactor. [ 11 ] A fl uidized or packed bed bioreactor containing microencapsulated hepatocytes appears promising in overcoming the limitations encountered with current liver support systems. [ 12, 13 ] In addition, injection of encapsulated hepatocytes intraperitoneally has been proposed to treat liver-associated inborn metabolic disease and acute liver failure as a better alternative to intrahepatic delivery of hepatocyte in suspension. [ 14, 15 ] The microgel layer (e.g., alginate) provides anchorage and protection against host immune attack for hepatocytes, leading to better cell viability and functions in the engraftment site. Maintaining functional longevity of hepatocytes in vitro to more closely refl ect the characteristics of liver in vivo is also the key to a more effective drug-screening platform. [ 16 ] It is particularly attractive to encapsulate hepatocyte spheroids owing to the improved cellular functions mediated by cell-cell interactions. [17] [18] [19] Traditionally, hepatocyte spheroids are generated before loading into microdroplets of hydrogel solution followed by polymerization. [ 20 ] To avoid clogging of spheroids in the nozzle or needle where microdroplet is generated, there exists a minimum diameter requirement of the nozzle/needle which leads to diffusional limitations and large transplant/device volume imposed by the size of capsule generated (500-1000 µm in diameter). [ 21 ] In addition, non-uniform distribution of spheroid in capsule following Poisson equation is observed, resulting in empty capsules and possible agglomeration of multiple spheroids. [ 22 ] Since billions of hepatocytes are required to recapitulate liver function in the case of liver failure, [ 8 ] the challenge of generating millions of hepatocyte spheroids and subsequently encapsulating them in a well-controlled and reproducible manner would be a hurdle to satisfy the Good Manufacturing Practice (GMP) for clinical translation.
Microfl uidics has emerged as a high-throughput platform for biochemical assays and bioprocessing. [ 23, 24 ] Employing microfl uidics to generate tiny monodisperse emulsion droplets creates microscale bioreactor and can be leveraged for scalable biomanufacturing of microencapsulated spheroids. [ 25 ] Earlier reports usually relied on formation of solid microgel or microcapsule encapsulating individual cells before the cells proliferated to form spheroids, which could take up to 5 d. [ 26, 27 ] In this study, we report a high-throughput double-emulsion (DE) (water-in-oil-in-water) platform that promotes cell assembly within the droplet in 4 h and subsequently induces the polymerization of the inner hydrogel phase to generate microencapsulated hepatocyte spheroids ( Figure 1 a) . We have previously shown that DE droplets can serve as platform for cell culture. [ 16, 28 ] Without any restriction on nozzle/needle size, the diameter of the microgel can be readily reduced to below 200 µm. Importantly, the inner phase of each droplet polymerizes individually to generate microgels all containing single spheroids. We demonstrate that the biochemical composition of the inner phase can be tuned to deliver appropriate cues for controlling hepatocyte behavior.
Besides matrix microenvironment, hepatocytes are surrounded by various types of cells such as endothelial cells, Kupffer cells, and stellate cells in liver. In order to recapitulate the different types of heterocellular interactions present in liver, many attempts have focused on co-culturing hepatocytes with other cell types such as liver sinusoidal endothelial cells (LSEC), umbilical vein endothelial cells (HUVEC), Kupffer cells, stellate cells, or even fi broblasts and mesenchymal stem cells. [29] [30] [31] [32] In general, hepatocyte functions are enhanced and sustained with co-culture. Among the supporting cell types tested, endothelial cells are attractive as co-culture of hepatocytes and endothelial cells emulates the in vivo situation where the two cell types form a continuous lining along the sinusoid separated by the space of Disse. [ 33 ] Endothelial cells also contribute to vascularization of ex vivo engineered constructs to increase oxygen and nutrients supply, [ 34 ] and to mimic human physiological system. [35] [36] [37] In view of the invasive collection or limited supply of LSEC and HUVEC, we explored the feasibility of using endothelial progenitor cells (EPC) as an alternative supporting cell source. EPC are highly proliferative, able to differentiate into endothelial cells, and available from umbilical cord as well as adult peripheral blood. [ 38, 39 ] Moreover, EPC express liver morphogen such as hepatocyte growth factor (HGF) which has been shown to stimulate albumin production in hepatocytes. [ 40, 41 ] Therefore, we hypothesized that co-culture of hepatocytes and EPC could enhance hepatocyte functions just like a conducive microenvironment does. To our best knowledge, this is the fi rst study which researched into the co-culture of hepatocytes and EPC.
Results

Generation of DE Droplet and Hepatocyte Spheroid-Encapsulated Microgel
Monodisperse DE droplet (≈200 µm in inner phase diameter) was generated (>20 Hz) using two connected microfl uidics fl ow-focusing devices (200 µm in channel width and depth) made from polydimethylsiloxane (PDMS) ( The biochemical composition of the droplet inner phase could be precisely controlled to modulate hepatocyte functions. To demonstrate, 0.25 mg mL −1 rat tail collagen I was added to the alginate solution, which was applied as the inner phase of droplet. Collagen I is one of the native extracellular matrix components and can be found in tissues like tendons, ligaments, and skin. It maintains hepatocyte functions efficiently when used as a substrate matrix during culture, [ 42 ] and can also serve as an immune-protective material. [ 19 ] Immunostaining of the spheroids encapsulated in microgels after their formation verifi ed the presence of collagen fi brils around both human HEK-293 and rat hepatocyte spheroids, suggesting the collagen fi brils did not originate from the rat hepatocytes and could supply biochemical and mechanical cues in microscale range (Figure 2 d ).
Characterization of Hepatocytes Cultured in 2D and 3D
Maintaining long-term hepatocyte functions has been a challenge of liver tissue engineering. Collagen sandwich is the current gold standard of culturing hepatocytes in 2D. [ 42 ] In a collagen-sandwich confi guration, hepatocytes were situated between two layers of collagen gel and exposed to microenvironment cues in a pseudo-3D confi guration where they displayed normal cubic cell shape with tight cell-cell junctions after 7 d of culture, a feature that was lost when the top collagen layer was absent ( Figure 3 a) . Using hepatocytes cultured in the collagen sandwich confi guration (Col-sandwich) as a 2D control, the performance of the microencapsulated hepatocyte spheroids with different microscale niche was compared. After 24 d of culture, hepatocyte spheroids maintained their compact, spherical morphology and viability in alginatecollagen (Alg-col) microgels, whereas the two features were lost in hepatocyte spheroids encapsulated in alginate (Alg) microgels (Figure 3 b) . Hepatocytes cultured in Col-sandwich could also maintain the morphology and viability over the course of 24 d. 5(6)-Carboxy-2′,7′-dichlorofl uorescein diacetate (CDFDA) staining indicated the activity of the MRP-2 transporter and formation of bile canaliculi in all three cases. In the case of Col-sandwich, channel-like canaliculi were observed in some regions, whereas the spheroid samples displayed patchy and increased amount of signals. Functional assessments showed that the amount of albumin synthesized by hepatocytes per day in Alg-col was higher than the other small 2016, 12, No. 20, 2720-2730 Figure 1 . a) Schematic diagram of the process of generating microencapsulated hepatocyte spheroid using DE droplet. In the fi rst device, waterin-oil (cell suspension: red; oil: blue) emulsion droplets were generated, which were transferred to the second device where an external water phase (green) wrapped around the single emulsion to produce DE droplets. b) Microfl uidics devices assembled on a glass microscope slide (75 mm × 25 mm). c) DE droplet generation (Left: Aqueous-oil droplets generated in fi rst device. Middle: Aqueous-oil-aqueous droplets generated in second device. Right: Appearance of droplets after collection). (Scale bar = 200 µm).
www.small-journal.com two cases on day 12, 16, and 18 ( Figure 4 a) , and the cumulative amount of albumin synthesized was also signifi cantly higher than the other two cases (Figure 4 b) . Hepatocytes encapsulated in Alg-col synthesized signifi cantly more urea on a few days but there was no signifi cant difference in the cumulative level of release (Figure 4 c,d ). Finally, cytochrome P450 3A4 (CYP3A4) luminogenic assay revealed that the basal level of CYP3A4 activity of hepatocytes in Alg-col was ≈4-5-fold and ≈15-fold higher than those in Alg and Col-sandwich at day 16 and 24, respectively (Figure 4 e). The induction of CYP3A4 activity (3-5-fold) upon 10 × 10 −6 m dexamethasone exposure of all three cases conformed with results reported in literature (Figure 4 f) . [ 43 ] Overall, the results of this experiment showed that hepatocytes in Alg-col exhibited the highest functions, while those in Alg and Col-sandwich performed similarly but inferiorly. The results also implied that both 3D culture confi guration with extensive cell-cell interactions and a conducive matrix microenvironment are important to maintaining hepatocyte functions. Given that other proteins such as fi bronectin and hyaluronic acid can be incorporated in our system readily, our technology holds promise to screen for optimal matrix microenvironment for spheroid culture in many applications.
Investigation of the Co-Culture of EPC and Hep
As a fi rst step of the co-culture experiment, different media formulations were tested to determine the optimal cell culture conditions for both types of cells. EGM-2, the culture medium for EPC, was mixed with hepatocyte medium at assorted ratios for screening. The proliferation and viability of EPC decreased as the fraction of hepatocyte medium increased while hepatocyte viability was poor when they were cultured in EGM-2. The cumulative albumin and urea secretions were not signifi cantly different when the hepatocyte medium constituted 50% or 66% of the co-culture medium ( Figure S4 , Supporting Information). Consequently, a 1:1 mixture of EGM-2 and hepatocyte medium was selected to best preserve the functions and viability of EPC and hepatocytes, respectively.
Next, various ratios (5:1, 3:1, 1:1, 1:3) of hepatocytes and EPC were mixed and encased into DE droplets to generate co-culture spheroids encapsulated in alginate microgels. Before loaded into droplets, the two cell types were labeled with different cell tracker markers to assess their organization in the composite spheroid ( Figure 5 a) . Analysis on the fl uorescent images taken with the spheroids showed that at low hepatocyte to EPC ratio, EPC tended to envelop individual hepatocytes. When their numbers were approximately equal, the two cell types distributed evenly. As hepatocyte fraction increased, hepatocytes preferentially aggregated, leaving the EPC on the periphery. Functional assessments showed that EPC improved hepatocyte performance (syntheses of albumin and urea, basal activity of CYP3A4) signifi cantly when the ratio of hepatocyte to EPC was 5:1 ( Figure 5 b-d) increased. While our data confi rmed that EPC could support hepatocyte functions in a co-culture spheroid confi guration, the infl uence was only observed at certain cell-to-cell ratio. At some other ratios (1:1 and 1:3) the effect was even opposite where hepatocyte performance was below that of control.
One possible explanation is that, as EPC fraction increased, homocellular interactions among hepatocytes were disrupted which could not be substituted with heterocellular infl uence from EPC. This might have a larger effect on albumin secretory ability of the cells than production of urea and cytochrome activity, as seen by the signifi cantly lower level of albumin secretion in the case of 1:3. Further research will be needed to understand the mechanisms of co-culture effect and prove the hypothesis.
Combination of Heterocellular Infl uence and Conducive Matrix Cue
Finally, we aimed at investigating whether conducive matrix cues would complement heterocellular interactions to further increase hepatocyte performance synergistically. Hepatocyte spheroids encapsulated in Alg-col (Hep in Alg-col), co-culture spheroids (5:1 ratio) encapsulated in Alg (HepEPC in Alg) and Alg-col (HepEPC in Alg-col) were generated and analyzed ( Figure 6 a) . The spheroids were immunofl uorescently stained to discern the two distinct types of cells. Staining for albumin and von Willibrand factor (vWF) indicated strong staining from hepatocytes and the presence of EPC. Sign of angiogenesis was observed in some spheroids encapsulated in either alginate or alginate-collagen ( Figure S5 , Supporting Information). The viability of all three cases was well preserved at day 14 and formation of bile canaliculi was also observed. The amount of cumulative albumin synthesized was comparable between Hep in Alg-col and HepEPC in Alg and signifi cantly higher in HepEPC in Alg-col (Figure 6 b) while the difference in urea secretion was not signifi cantly different (Figure 6 c) . For basal CYP3A4 activity, the levels of three cases were not signifi cantly different at day 8, however HepEPC in Alg-col recorded signifi cantly higher level of activity (≈2 times of other groups) at day 16 ( Figure 6 d) . Applying 10 × 10 −6 m dexamethasone to HepEPC in Alg-col induced CYP3A4 activity by fi vefold which was again consistent with literature data (Figure 6 e). [ 43 ] Overall, our data suggested that matrix cues from collagen exerted a similar supporting effect to coculture with EPC on hepatocytes, and hepatocytes responded to both types of infl uence when they were supplied simultaneously. This example is a clear manifestation of the capability of our technology in optimizing both cell-cell and www.small-journal.com cell-extracellular matrix interactions for hepatocyte spheroid encapsulation.
Discussion
Microencapsulated hepatocyte spheroids can be applied in the fl uidized bed of bioreactor for bioartifi cial liver, direct injection into the peritoneal space, or drug screening platform. [ 11, 31, 44 ] Our technology, in particular, offers certain benefi ts over traditional microencapsulation technology. First of all, the microgel size is smaller than 200 µm containing a spheroid of ≈80 µm. This is hard to achieve with existing technology as the needle/nozzle size would be restrained by the size of spheroids encapsulated and shear force exerted on cells, resulting in a size range of 500-1000 µm of the microgel/ microcapsule generated. [ 21 ] Reducing the microgel/microcapsule size would defi nitely be advantageous as the hydrogel layer has proven a signifi cant barrier to the diffusion of large molecules. Literature data showed that it took 15 min versus 1 h for the release of bovine albumin serum to reach equilibrium from alginate gels of 400 µm and 1 mm in diameter, respectively. [ 45 ] Our data showed that it took longer, though not signifi cantly, for albumin to diffuse out from the 300 µm microgels than the 122 µm ones, demonstrating microgels with larger surface-to-volume ratio enables faster diffusion ( Figure 7 ). Since many of the liver's substrates for detoxification and synthetic products are large molecules, the presence of a diffusion barrier associated with the immobilization materials may partially explain why so few, if not none, of the existing bioartifi cial livers have attained satisfactory results in clinical trials. [ 9 ] From a clinical point of view it is also important to decrease the total device volume by using smaller microgels in order to reduce patients' extracorporeal plasma compartment and hence prevent hypotension occurring in patients. [ 46 ] Second, perhaps more importantly, our technology produces microgels containing single spheroid, in contrast to a Poisson-distributed fashion. The latter scenario will lead to possible agglomeration of multiple spheroids within a single microgel/microcapsule, compromising molecular transport to and from a fused spheroid. There is wide consensus that necrosis in spheroid core will occur if the spheroid size is larger than ≈150 µm, [ 47 ] which is likely to happen in the event of spheroid fusion within the microgel/ microcapsule. Our high-throughput technology also circumvents the need to purify the microencapsulated spheroids from empty capsules. This would be crucial if a suffi cient number (in the order of million/billion) of microgels/microcapsules are to be generated with high yield and uniformity to satisfy GMP for clinical applications. Last but not least, the DE technology we embraced provides one-step generation of microencapsulated hepatocyte spheroids whereas other technologies require formation of spheroid before microencapsulation. [ 22 ] The biochemical composition of the encapsulation materials and cell composition in spheroid could be fl exibly tuned to enhance and maintain hepatocyte functions. In the current study, the alginate and alginate-collagen used exhibit different biochemical as well as mechanical properties. [ 27 ] It is diffi cult to uncouple the effects of each cue. In future work, we will explore the effect of mechanical property alone such as using alginate of various concentrations on hepatocyte functions and viability. The use of EPC as a novel supporting cell type to enhance hepatocyte functions opens up new opportunities in maintaining long-term hepatocyte functions by co-culture with cell types that are not immortalized or obtained via invasive means. Nevertheless, the fact that at certain co-culture ratios the benefi cial effect was lost means that further research should be devoted to studying the mechanism of the phenomenon and optimizing the process. 
Conclusion
In this study, we demonstrated the effi cient one-step production of microencapsulated hepatocyte spheroids with high yield, versatility, and uniformity via the generation of microfl uidics DE droplet. We showed that the incorporation of collagen in the encapsulation materials and EPC (hepatocyte to EPC ratio = 5:1) as a novel supporting cell source would enhance the long-term performance of hepatocytes. We envision the technology can be adopted to screen for optimal matrix environment and cell composition, and can be the platform for biomanufacturing of microencapsulated spheroids for various liver tissue engineering and medical applications. hydrocortisone (Sigma Aldrich, St. Louis, MO), and 100 U mL −1 penicillin/streptomycin (Life Technologies, Grand Island, NY). For collagen sandwich culture, neutralized 20 µg cm −2 type I bovine dermal collagen (BD Biosciences, San Jose, USA) was coated on culture well for 1 h for cell seeding. Another layer of collagen gel was overlaid 24 h after initial cell seeding. Human umbilical cord blood-derived EPC were isolated as previously described. [ 48 ] Umbilical cord blood was obtained from the Carolina Cord Blood Bank. All patient identifi ers were removed prior to receipt. The protocol for the collection and the usage of human blood in this study was approved by the Duke University Institutional Review Board. EPC were cultured in EGM-2 BulletKit (Lonza, Walkersville, MD) supplemented with 10% FBS and used within passage 3-5. HEK-293 cells were purchased from American Type Culture Collection (Manassas, VA) and cultured in DMEM supplemented with 10% FBS and 100 U mL −1 penicillin/streptomycin. To determine the optimal coculture medium composition, the Hep and EPC media were mixed at various ratios (1:0, 1:1, 2:1) and used to culture Hep and EPC, respectively. The viability and vWF expression of EPC were analyzed while the albumin and urea secretions of Hep were assessed to determine the optimal culture conditions for both types of cells.
Experimental Section
Microfl uidics Device Fabrication and DE Generation : Two fl owfocusing microfl uidics devices with a channel width and height of 200 µm and 100 µm were fabricated according to a reported protocol. [ 16, 49 ] The procedure of generating DE was described in the main text. Briefl y, cell culture medium or alginate (PRONOVA SLG100, Novamatrix, Norway) dissolved in cell culture medium (1%) was used as the inner aqueous phase. The oil phase used was HFE-7500 (Miller-Stephenson Chemical Co. Inc., Danbury, CT) supplemented with Pico-Surf TM 2 surfactant (1%) (Dolomite Microfl uidics, Charlestown, MA). The external aqueous phase comprised culture medium supplemented with Pluronic F-127 (2.5 wt%). The fl ow rates of inner aqueous phase (4 mL min −1 ), middle oil phase of HFE7500 (3 M , St. Paul, MN) (12 mL min −1 ), and external aqueous (24 mL min −1 ) were controlled by a Harvard Apparatus PHD 2000 Syringe Pump. To create alginate microgel after droplet formation, DE containing alginate solution were dispersed onto a cell strainer with pore size of 70 µm. 200 × 10 −3 M calcium chloride solution was pipetted onto the droplets for a few times. After the oil phase was washed through the strainer and microgels were formed and trapped on the strainer, the strainer was fl ipped upside down before 150 × 10 −3 M sodium chloride solution was pipetted on top to wash the microgels down for collection. The microgels were washed with 150 × 10 −3 M sodium chloride solution for a few times to remove excess calcium chloride solution. To track the organization of co-culture cell types in the composite spheroid, EPC and Hep were labeled with CellTracker Green CMFDA Dye and CellTracker Red CMTPX Dye, respectively, before loaded into DE to form composite spheroids. The microencapsulated spheroids were imaged using the inverted confocal microscope at day 0 and 1. MRP-2 Transporter Activity : 5(6)-Carboxy-2′,7′-dichlorofl orescein diacetate (CDFDA) (Sigma Aldrich, St. Louis, MO) was used as the substrate to detect MRP-2 transporter activity and thus bile canaliculi formation. The samples were incubated with 5 × 10 −6 M CDFDA for 30 min. Thereafter, dye solution was aspirated and the cells were washed with PBS for a few times before imaged using the inverted confocal microscope.
Immunostaining : For immunostaining against collagen I, the microgels were fi rst added to 50 × 10 −3 M sodium citrate solution for 5 min to dissolve the alginate layer before stained with collagen I primary antibody (PA1-27397) and the corresponding secondary antibody (31573). For immunostaining against albumin and vWF, the microgels were again treated with sodium citrate before permeabilized with 0.1% Triton X-100 solution for 30 min. The antibodies used were vWF antibody (PA5-16634) and the corresponding secondary antibody (31670), and albumin antibody conjugated with FITC (PA1-86695). All antibodies were purchased from Thermo Scientifi c (Waltham, MA). The samples were then fi xed in FluoroGel mounting medium (Electron Microscopy Sciences, Hatfi eld, PA) before imaged using the inverted confocal microscope (Zeiss LSM 510) available at Duke Light Microscopy Core Facility.
Albumin ELISA Quantifi cation : The single and co-culture microgels were cultured in Hep and the optimized co-culture media, respectively. Hep in Col-Sandwich condition were cultured in Hep medium. The culture media were changed and collected once every 2 d. The samples were analyzed using rat albumin ELISA quantifi cation kit (Bethyl Laboratories, Montgomery, TX) following the manufacturer's protocol and the absorbance was determined with the FLUOstar OPTIMA Microplate Reader (BMG Labtech, Germany).
Urea Assay : The samples were analyzed for urea secretion using Urea Nitrogen (BUN) Test (Stanbio Laboratory, Boerne, TX) following the manufacturer's protocol and the absorbance was determined with the FLUOstar OPTIMA microplate reader (BMG Labtech, Germany).
Cytochrome P450 3A4 (CYP3A4) Assay and Induction : At day 8, 16, ad 24, the cell culture samples were treated with CYP3A4 assay www.small-journal.com substrate (Promega, Madison, WI) following the manufacturer's protocol before the luminescence was analyzed with the FLUOstar OPTIMA microplate reader (BMG Labtech, Germany). Dexamethasone (Dex) is a known inducer for CYP3A4 enzymatic activity. To perform the induction, the cell culture samples were pretreated with 10 × 10 −6 M Dex for 72 h prior to analysis.
Statistical Analysis : All results (single-/co-culture experiments) were reported as the mean ± S.E.M. for three independently performed experiments. Statistical signifi cance was determined using one-or two-way ANOVA followed by Tukey's Post Test (Prism 5.0, GraphPad Software, La Jolla, CA). The albumin, urea, and CYP3A4 results were reported as amount per 10 6 cells where the number of cells in each sample was determined by counting cells after trypsination or Accutase (Life Technologies, Grand Island, NY) treatment. In the case of co-culture experiment, the results were normalized with the number of hepatocytes present in the spheroid.
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